Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Jefferson Research
$20.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Covidien PLC Lowers FY 2013 Revenue Guidance


Friday, 3 May 2013 04:01pm EDT 

Covidien PLC announced that for fiscal 2013, it estimates that net sales 4% to 5% growth. The Company reported revenue of $11.852 billion in fiscal 2012. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $12.492 billion for fiscal 2013. 

Related Company News

Company Quote

103.21
-0.14 -0.14%
26 Dec 2014